ZIM Laboratories Limited (BOM:541400)
68.22
-0.36 (-0.52%)
At close: Mar 4, 2026
ZIM Laboratories Revenue
ZIM Laboratories had revenue of 1.09B INR in the quarter ending December 31, 2025, with 12.80% growth. This brings the company's revenue in the last twelve months to 3.78B, down -2.65% year-over-year. In the fiscal year ending March 31, 2025, ZIM Laboratories had annual revenue of 3.79B with 3.16% growth.
Revenue (ttm)
3.78B
Revenue Growth
-2.65%
P/S Ratio
0.87
Revenue / Employee
6.55M
Employees
577
Market Cap
3.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.79B | 116.16M | 3.16% |
| Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
| Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
| Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
| Mar 31, 2021 | 3.07B | 295.19M | 10.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.23B |
| Amanta Healthcare | 2.83B |
| Medico Remedies | 1.91B |
| Everest Organics | 1.89B |
| Medicamen Biotech | 1.72B |
| Jenburkt Pharmaceuticals | 1.65B |
| Sat Kartar Life | 1.63B |
| Gennex Laboratories | 1.52B |
ZIM Laboratories News
- 17 days ago - Zim Laboratories Ltd (BOM:541400) Q3 2026 Earnings Call Highlights: Strong Export Growth Amid ... - GuruFocus
- 17 days ago - Q3 2026 ZIM Laboratories Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 7 months ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 8 months ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn